| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| SPS(R) | 119 | 31.3% | -0.49 | 85 | 63.0% |
| IB | 69 | 18.2% | -0.46 | 50 | 37.0% |
| SPS(L) | 82 | 21.6% | -inf | 0 | 0.0% |
| IPS(L) | 81 | 21.3% | -inf | 0 | 0.0% |
| CentralBrain-unspecified | 27 | 7.1% | -inf | 0 | 0.0% |
| PLP(L) | 2 | 0.5% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns CB1997_b | % In | CV |
|---|---|---|---|---|---|
| PS063 (R) | 1 | GABA | 100 | 26.4% | 0.0 |
| IB045 (R) | 2 | ACh | 24 | 6.3% | 0.3 |
| MeVPMe8 (L) | 2 | Glu | 17 | 4.5% | 0.2 |
| WED210 (L) | 1 | ACh | 14 | 3.7% | 0.0 |
| GNG545 (R) | 1 | ACh | 13 | 3.4% | 0.0 |
| MeVPMe8 (R) | 2 | Glu | 13 | 3.4% | 0.8 |
| IB045 (L) | 2 | ACh | 13 | 3.4% | 0.7 |
| MeVP6 (L) | 7 | Glu | 13 | 3.4% | 0.3 |
| AN04B023 (L) | 1 | ACh | 12 | 3.2% | 0.0 |
| PS081 (R) | 1 | Glu | 11 | 2.9% | 0.0 |
| MeVP59 (L) | 1 | ACh | 10 | 2.6% | 0.0 |
| MeVPMe5 (R) | 3 | Glu | 8 | 2.1% | 0.4 |
| CB1997 (L) | 3 | Glu | 7 | 1.8% | 0.2 |
| PS061 (R) | 1 | ACh | 6 | 1.6% | 0.0 |
| AN06B011 (R) | 1 | ACh | 6 | 1.6% | 0.0 |
| LPT59 (R) | 1 | Glu | 6 | 1.6% | 0.0 |
| CB0194 (R) | 1 | GABA | 5 | 1.3% | 0.0 |
| HST (L) | 1 | ACh | 5 | 1.3% | 0.0 |
| MeVC2 (R) | 1 | ACh | 5 | 1.3% | 0.0 |
| AOTU005 (L) | 1 | ACh | 5 | 1.3% | 0.0 |
| DNpe012_a (L) | 2 | ACh | 5 | 1.3% | 0.6 |
| PS156 (R) | 1 | GABA | 4 | 1.1% | 0.0 |
| vCal3 (R) | 1 | ACh | 4 | 1.1% | 0.0 |
| LPT31 (L) | 2 | ACh | 4 | 1.1% | 0.5 |
| CB0734 (L) | 2 | ACh | 4 | 1.1% | 0.0 |
| PLP143 (R) | 1 | GABA | 3 | 0.8% | 0.0 |
| PS159 (R) | 1 | ACh | 3 | 0.8% | 0.0 |
| vCal2 (R) | 1 | Glu | 3 | 0.8% | 0.0 |
| ATL031 (R) | 1 | unc | 3 | 0.8% | 0.0 |
| OA-VUMa6 (M) | 1 | OA | 3 | 0.8% | 0.0 |
| PS272 (R) | 2 | ACh | 3 | 0.8% | 0.3 |
| AMMC013 (L) | 1 | ACh | 2 | 0.5% | 0.0 |
| SMP048 (R) | 1 | ACh | 2 | 0.5% | 0.0 |
| GNG308 (L) | 1 | Glu | 2 | 0.5% | 0.0 |
| PS177 (R) | 1 | Glu | 2 | 0.5% | 0.0 |
| PS242 (R) | 1 | ACh | 2 | 0.5% | 0.0 |
| PS082 (R) | 1 | Glu | 2 | 0.5% | 0.0 |
| PS157 (R) | 1 | GABA | 2 | 0.5% | 0.0 |
| GNG311 (R) | 1 | ACh | 2 | 0.5% | 0.0 |
| AN06B009 (L) | 1 | GABA | 2 | 0.5% | 0.0 |
| OA-AL2i4 (L) | 1 | OA | 2 | 0.5% | 0.0 |
| WED210 (R) | 1 | ACh | 2 | 0.5% | 0.0 |
| CB1641 (L) | 2 | Glu | 2 | 0.5% | 0.0 |
| PS221 (L) | 2 | ACh | 2 | 0.5% | 0.0 |
| DNp27 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LoVP_unclear (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| IB016 (R) | 1 | Glu | 1 | 0.3% | 0.0 |
| LAL149 (R) | 1 | Glu | 1 | 0.3% | 0.0 |
| LAL145 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CB2956 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| PS087 (R) | 1 | Glu | 1 | 0.3% | 0.0 |
| CB2694 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| PS286 (R) | 1 | Glu | 1 | 0.3% | 0.0 |
| DNpe014 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CB1222 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| PLP231 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| PLP231 (R) | 1 | ACh | 1 | 0.3% | 0.0 |
| ATL031 (L) | 1 | unc | 1 | 0.3% | 0.0 |
| PS052 (R) | 1 | Glu | 1 | 0.3% | 0.0 |
| GNG547 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| LoVCLo2 (R) | 1 | unc | 1 | 0.3% | 0.0 |
| PS196_b (R) | 1 | ACh | 1 | 0.3% | 0.0 |
| MeVP57 (R) | 1 | Glu | 1 | 0.3% | 0.0 |
| PS159 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LoVC22 (R) | 1 | DA | 1 | 0.3% | 0.0 |
| downstream partner | # | NT | conns CB1997_b | % Out | CV |
|---|---|---|---|---|---|
| ATL031 (R) | 1 | unc | 32 | 12.1% | 0.0 |
| PS050 (R) | 1 | GABA | 27 | 10.2% | 0.0 |
| IB118 (R) | 1 | unc | 23 | 8.7% | 0.0 |
| ATL021 (R) | 1 | Glu | 23 | 8.7% | 0.0 |
| ATL031 (L) | 1 | unc | 20 | 7.6% | 0.0 |
| LAL147_c (R) | 1 | Glu | 13 | 4.9% | 0.0 |
| IB005 (R) | 1 | GABA | 11 | 4.2% | 0.0 |
| PS107 (R) | 2 | ACh | 10 | 3.8% | 0.2 |
| IB116 (R) | 1 | GABA | 9 | 3.4% | 0.0 |
| DNp54 (R) | 1 | GABA | 8 | 3.0% | 0.0 |
| IB051 (R) | 2 | ACh | 8 | 3.0% | 0.5 |
| PLP216 (R) | 1 | GABA | 7 | 2.7% | 0.0 |
| ATL032 (R) | 1 | unc | 6 | 2.3% | 0.0 |
| PS157 (R) | 1 | GABA | 6 | 2.3% | 0.0 |
| CL160 (R) | 2 | ACh | 6 | 2.3% | 0.3 |
| DNp08 (R) | 1 | Glu | 5 | 1.9% | 0.0 |
| PS263 (R) | 2 | ACh | 5 | 1.9% | 0.2 |
| PS231 (R) | 1 | ACh | 4 | 1.5% | 0.0 |
| CB4096 (L) | 2 | Glu | 4 | 1.5% | 0.5 |
| WED076 (L) | 1 | GABA | 3 | 1.1% | 0.0 |
| PLP143 (R) | 1 | GABA | 3 | 1.1% | 0.0 |
| IB045 (R) | 1 | ACh | 3 | 1.1% | 0.0 |
| LAL146 (R) | 1 | Glu | 3 | 1.1% | 0.0 |
| ATL021 (L) | 1 | Glu | 3 | 1.1% | 0.0 |
| CB1227 (R) | 2 | Glu | 3 | 1.1% | 0.3 |
| PS240 (R) | 1 | ACh | 2 | 0.8% | 0.0 |
| ATL003 (R) | 1 | Glu | 2 | 0.8% | 0.0 |
| PS156 (R) | 1 | GABA | 2 | 0.8% | 0.0 |
| DNpe027 (R) | 1 | ACh | 2 | 0.8% | 0.0 |
| CB2694 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB1997 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| ATL042 (L) | 1 | unc | 1 | 0.4% | 0.0 |
| ATL030 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| IB101 (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| PS063 (R) | 1 | GABA | 1 | 0.4% | 0.0 |
| DNg79 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| IB023 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| VES056 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| WED076 (R) | 1 | GABA | 1 | 0.4% | 0.0 |
| LoVC19 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
